Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'prep hiv'
prep hiv published presentations and documents on DocSlides.
HIV Medication Overview
by kittie-lecroy
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...
Preparing for PrEP Choice: Key Programmatic
by olivia-moreira
Preparing for PrEP Choice: Key Programmatic Consid...
Malawi Path to Scale study and programmatic considerations that are guiding the country program
by jadiel
Welcome to the era of PrEP choice. Rose Nyirenda, ...
Delivering Telemedicine Public Health Infectious College Access
by ryder666
PrEP. through . Telemedicine and Public . Health ...
PROUD: Results and participant experiences
by catherine
Presented by . Mitzy. . Gafos. , behalf of the P...
HIV Prevention Initiative:
by claire
Integrating . PrEP. into PP Health Centers. Court...
STIs in PrEP Users : Are
by jones
W. e. . Propelling. the . Epidemic. ?. Jean-Mich...
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
Dapivirine Ring Introduction Framework and Key Insights
by valerie
PLAN. 4 . RING . TOOLKIT. PROMISE. Preparing for ...
Gaston Djomand (CDC) &
by ash
Chris Obermeyer (USAID). on behalf of the interage...
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
IMPAACT Community and Science HIV Prevention
by VanillaSky
. DICHABA SIANE. ICAB Member. FOCAL POPULATION Y...
Long-acting Capsid Inhibitor Effective as
by CottonTails
PrEP. Against Vaginal SHIV Transmission in Macaqu...
Use of data to monitor and improve
by heartfang
key-population-focused programming . Navindra Pers...
Optimizing the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral te
by groundstimulus
PrEP. Kenneth Mugwanya, . Renee Heffron. , Christi...
HPTN 082: Evaluation
by test
HPTN 082: Evaluation of daily oral PrEP as a pri...
Frequent detection of TFV-DP among
by mitsue-stanley
Frequent detection of TFV-DP among young Kenyan ...
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
Training, Communication, and Prescribing Patterns of
by celsa-spraggs
Training, Communication, and Prescribing Patterns...
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW
by calandra-battersby
Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE S...
OPTIONS 2018 HIV R4P Conference Neeraja Bhavaraju, FSG October 2018
by trish-goza
OPTIONS 2018 HIV R4P Conference Neeraja Bhavaraju...
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by alida-meadow
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by tawny-fly
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Module 2: THE PROVISION OF ORAL
by pasty-toler
PrEP. . IN THE CONTEXT OF AGYW . Version: Augus...
Clinical Management Module
by yoshiko-marsland
4. . (a) . Getting . started on . PrEP. Session ...
Leveraging Social Network Applications
by trish-goza
for . Evaluating Changes in PrEP Outcomes. Los An...
Situation Analysis Toolkit
by pamella-moone
Step 3: Summary Findings. APRIL. 2016. This toolk...
New Prevention Technologies Workshop
by olivia-moreira
Module 5: . State of NPT Research. www.icad-cisd....
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
The potential role
by danika-pritchard
of . HIV . self-testing within . pre-exposure . p...
A. D. Smith,
by pasty-toler
1. A. Muhaari . 2. E. M. van der Elst . 2. D. ...
Doxycycline Post-Exposure Prophylaxis
by shawn295
to Prevent Bacterial Sexually . Transmitted Infect...
Summary of differentiated service delivery at IAS 2021
by stella
Review . from. . the. . Differentiated. Service...
Selected Gilead- initiated
by amey
. or. Gilead-supported Abstracts . Published. at...
Getting to Zero with primary care: Pharmacy home visits and providers view of
by mackenzie
PrEP. Mackie King, PharmD, BCPS, CPP. a. ; Nancy W...
Sabrina Spinosa Guzman Janssen Protocol Chair
by teresa
. HVTN satellite. 21. st. July 2019. HIV Vaccine ...
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
CAHR 2019 Scientific summary of the major clinical studies presented at the 28th Annual Canadian Co
by osullivan
Résumé scientifique des principales études clin...
CROI 2019 Scientific summary of the major clinical studies presented at CROI 2019
by blanko
Résumé scientifique des principales études clin...
Load More...
